Avéma Pharma Solutions is a Contract Development and Manufacturing Organization (CDMO) that supports the pharmaceutical industry by providing comprehensive services from concept to commercialization. Specialising in both prescription (Rx) and over-the-counter (OTC) products, Avéma develops and manufactures oral liquid and solid dose units including suspensions, solutions, tablets, and capsules. They offer a diverse range of delivery technologies, including immediate release systems, modified release systems, delayed-release and extended-release formulations, chewable tablets, quick dissolve tablets, two-piece hard-shell capsules, and taste masking. With over three decades of dedication to quality and efficiency, Avéma Pharma Solutions is committed to helping clients bring their products to market swiftly and at the highest possible quality.

Services include:
- 505(b)(2)
- Accelerated Stability Studies
- Analytical Services
- Animal Health
- API Solubilization Technologies
- Assay Development
- Blending
- Clinical Supply Management
- Clinical Trials Management
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Contract Packaging
- Contract Research (CRO)
- Manufacturing
- Dosage Form Development
- Drug Development
- Fluid Bed Processing
- Process Development
- Formulation Development
- Controlled Release
- Capsule
- Clinical Trial Materials
- Controlled Substances
- Dose Form
- Non-Sterile
- Oral Drug Delivery
- Orally Dispersible Tablet
- OTC
- Powders
- Solid Dosage
- Solutions & Suspensions
- Packaging
- Blister
- Liquids
- Plastic Bottles and Jars
- Pouches
- Process R&D
- Process Validation Studies
- Project Management
- Quality QA/QC
- R&D Services
- Tablet Coating
- Laboratory and Analytical Services

Avéma Pharma Solutions continues to uphold its reputation for quality service and integrated, end-to-end solutions within the pharmaceutical landscape. For more information, please visit avemapharma.com.